Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
REGENXBIO
Biotech
Regenxbio starts pivotal study for DMD gene therapy
Regenxbio’s gene therapy improved muscle function for patients with DMD in a phase 1/2 study, with the biotech rolling the trial into a pivotal study.
Gabrielle Masson
Nov 18, 2024 2:24pm
J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders
Jun 14, 2024 8:30am
Adverum's gene therapy reduces treatment burden in wet AMD
Feb 8, 2024 11:17am
Regenxbio-AbbVie in-office gene therapy clears phase 2 test
Jan 17, 2024 9:42am
SQZ lays off 80% of staff, Regenxbio cuts 15%
Nov 9, 2023 8:23am
Chasing Pfizer, Regenxbio benefits from FDA boost in DMD
Apr 11, 2023 9:45am
